Caprock Group, Inc. Takeda Pharmaceutical CO LTD Transaction History
Caprock Group, Inc.
- $3 Billion
- Q4 2024
A detailed history of Caprock Group, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Caprock Group, Inc. holds 25,913 shares of TAK stock, worth $350,862. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,913
Previous 34,304
24.46%
Holding current value
$350,862
Previous $487,000
29.57%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding TAK
# of Institutions
335Shares Held
69.1MCall Options Held
1.99MPut Options Held
171K-
Capital Research Global Investors Los Angeles, CA13.2MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$75.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$62.7 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$57.1 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$43.9 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...